Report of Foreign Issuer (6-k)
December 06 2012 - 8:43AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2012
Commission File Number: 001-34541
|
CHINA CORD BLOOD CORPORATION
|
|
|
(Translation of registrant’s name into English)
|
|
|
48th Floor, Bank of China Tower
|
|
|
1 Garden Road
|
|
|
Central
|
|
|
Hong Kong S.A.R.
|
|
|
(Address of Principal Executive Offices)
|
|
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Indicate by check mark whether the registrant
by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule
12g3-2(b) under the Securities Exchange Act of 1934.
If “Yes” is marked, indicate
below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.
This report and each of the exhibits
to this report are hereby incorporated by reference into the registration statements on Form F-3 (No. 333-168873 and No. 333-183143)
of the Company.
Entry into a Material Definitive
Agreement
On
December
6, 2012, Favorable Fort Limited (“Favorable Fort”), a subsidiary of China Cord Blood Corporation (the
“Company”), entered into a shares purchase agreement (the “Purchase Agreement”) with Cordlife Services
(S) Pte. Ltd., a company limited by shares incorporated in Singapore (“Cordlife Services”), pursuant to which Favorable
Fort is obligated to repurchase the 17% of its outstanding ordinary shares not already indirectly owned by the Company from Cordlife
Services for a total purchase price of approximately $8.65 million following satisfaction or waiver of all of the closing conditions
set forth in the Purchase Agreement.
A copy of the Purchase Agreement is attached
hereto as exhibit 4.1.
Exhibits
Exhibit No.
|
|
Description
|
4.1
|
|
Shares Purchase Agreement, dated December
6, 2012.
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
CHINA CORD BLOOD CORPORATION
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Albert Chen
|
|
|
Name:
|
Albert Chen
|
|
|
Title:
|
Chief Financial Officer
|
|
Dated:
December
6, 2012
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Oct 2023 to Oct 2024